Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide
5 NDCs across 1 manufacturer|5 Generic,0 Brand
▸ More about this market▾ Less
Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide is available as 5 NDCs from 1 manufacturer (5 generic, 0 brand), with NADAC prices from $0.74 to $1.13 per EA — a 52% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
5
5G / 0B
Manufacturers
1
competing in market
Price Spread
$0.74 – $1.13
per EA
7d Activity
avg -4.0% WoW · of 5 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5 | $1.1322 per EA | -6.81% |
OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-5-12.5 | $1.1082 per EA | -0.80% |
OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-25 MG | $1.0341 per EA | -9.38% |
OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-5-25 MG | $0.9151 per EA | +0.92% |
OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 20-5-12.5 | $0.7432 per EA | -3.91% |
Frequently Asked Questions
How many Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide products are on the market?
The Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide drug market contains 5 NDCs from 1 manufacturer — 5 generic and 0 brand products.
What is the price range for Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide?
NADAC reference prices for Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide range from $0.7432 to $1.1322 per EA — a 52% difference between cheapest and most expensive.
Which manufacturers make Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide?
1 manufacturer lists Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide in NADAC. Ranked by number of NDCs, the largest are Teva Pharmaceuticals USA Inc. (5).
How has the price of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide changed recently?
Over the past 7 days, 4 Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide NDCs rose and 16 fell, with a market-wide average change of -4.0%.